PF-05085727
|
|
- CAS号:
- 1415637-72-7
- 英文名:
- PF-05085727
- 英文别名:
- PF-05085727;PF05085727,PF 05085727;PF-05085727 >=98% (HPLC);4-(AZETIDIN-1-YL)-1-METHYL-3-(1-METHYL-5-(4-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOL-4-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE;1H-Pyrazolo[3,4-d]pyrimidine, 4-(1-azetidinyl)-1-methyl-3-[1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-
- 中文名:
- PF-05085727
- 中文别名:
- 化合物 T16482;4-(氮杂环丁烷-1-基)-1-甲基-3-(1-甲基-5-(4-(三氟甲基)苯基)-1H-吡唑-4-基)-1H-吡唑并[3,4-D]嘧啶
- CBNumber:
- CB95419808
- 分子式:
- C??H??F?N?
- 分子量:
- 413.4
- MOL File:
- 1415637-72-7.mol
|
|
|
PF-05085727化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO : 62.5 mg/mL (151.19 mM; Need ultrasonic)
-
|
PF-05085727性质、用途与生产工艺
PF-05085727 是一种强效的 cGMP 依赖性的 PDE2A (IC50=2 nM) 选择性和具有脑通透性的抑制剂。PF-05085727 对 PDE2A 的选择性是 PDE1 和 PDE3-11 的 4000 倍。
PF-05085727 shows weak activity with IC
50
of 162 μM to induce cell death in a cellular toxicity assay using transformed human liver endothelial (THLE) cells.PF-05085727 (3 μM) shows a minimal inhibition of cytochrome P450 enzymes (CYPs), inhibits 1A2, 2C8, 2C9, 2D6 and 3A4 with percentage% of 16%, 18%, 7%, 4%, and 30%, respectively.PF-05085727 (10 μM) inhibits PDE1B, PDE4B, PDE7B and PDE10A with IC
50
values of 12.146 μM, 22,503 μM, 13.157 μM and 6.515 μM, respectively.
PF-05085727 (subcutaneous injection; 3.2 mg/kg/mice; 3 mg/kg/rat) gives a ratio of unbound brain (C
bu
) to unbound plasma (C
pu
) of ca. 0.27 and 0.37, respectively.PF-05085727 in mice leads to an acute and exposure-dependent elevation in the accumulation of bulk levels of cGMP in cortex, striatum, and hippocampus as measured by enzyme-linked immunosorbent assay.
PF-05085727
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-102050 | PF-05085727 PF-05085727 | 1415637-72-7 | 5mg | 800元 |
2024/04/30 | HY-102050 | PF-05085727 PF-05085727 | 1415637-72-7 | 10mg | 1250元 |
1415637-72-7, PF-05085727 相关搜索:
- C20H18F3N7
- 化合物 T16482
- 4-(氮杂环丁烷-1-基)-1-甲基-3-(1-甲基-5-(4-(三氟甲基)苯基)-1H-吡唑-4-基)-1H-吡唑并[3,4-D]嘧啶
- 1415637-72-7
- PF05085727,PF 05085727
- PF-05085727 >=98% (HPLC)
- 1H-Pyrazolo[3,4-d]pyrimidine, 4-(1-azetidinyl)-1-methyl-3-[1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-
- 4-(AZETIDIN-1-YL)-1-METHYL-3-(1-METHYL-5-(4-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOL-4-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE
- PF-05085727